A Dose Response Trial to Evaluate Clinical and Mycological Effect of Nitric Oxide in Subjects With Tinea Pedis

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

January 31, 2010

Study Completion Date

May 31, 2010

Conditions

Tinea Pedis

Interventions

DRUG

1% gaseous Nitric Oxide blended in Oxygen

1% gaseous nitric oxide blended in oxygen applied for 30-60 minutes over 1-2 consecutive days.

Trial Locations (4)

Mediprobe Research, Inc, London

Eureka Health Services, Ramsbury Site

Diversified Healthcare Solutions, Basseterre

Medical Associates, Basseterre